Viktor Umansky

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 18

Top Topics

Induced Apoptosis

Basal Cell Carcinoma

Top Venues

Journal for immunotherapy of cancer

Nature reviews. Clinical oncology

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Samantha A Lasser, Feyza Gul Ozbay Kurt, Lennart Fritz, Nina Gutzeit, Carolina de la Torre, Peter Altevogt, Jochen Sven Utikal, Viktor Umansky
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in Melanoma. International journal of molecular sciences 25 (12) (2024)
Samantha A Lasser, Feyza Gul Ozbay Kurt, Ihor Arkhypov, Jochen Utikal, Viktor Umansky
Myeloid-derived suppressor cells in cancer and cancer therapy. Nature reviews. Clinical oncology (2024)
Samantha A Lasser, Feyza Gul Ozbay Kurt, Ihor Arkhypov, Jochen Utikal, Viktor Umansky
Myeloid-derived suppressor cells in cancer and cancer therapy. Nature reviews. Clinical oncology 21 (2) (2024)
Samantha A Lasser, Feyza Gul Ozbay Kurt, Lennart Fritz, Nina Gutzeit, Carolina de la Torre, Peter Altevogt, Jochen Sven Utikal, Viktor Umansky
Generation of Myeloid-Derived Suppressor Cells Mediated by MicroRNA-125a-5p in Melanoma. International journal of molecular sciences 25 (12) (2024)
Feyza Gul Ozbay Kurt, Beatrice-Ana Cicortas, Bianca M Balzasch, Carolina De la Torre, Volker Ast, Ece Tavukcuoglu, Cagla Ak, Sebastian A Wohlfeil, Adelheid Cerwenka, Jochen Utikal, Viktor Umansky
S100A9 and HMGB1 orchestrate MDSC-mediated immunosuppression in melanoma through TLR4 signaling. Journal for immunotherapy of cancer 12 (9) (2024)
Samantha A Lasser, Feyza Gul Ozbay Kurt, Ihor Arkhypov, Jochen Utikal, Viktor Umansky
Myeloid-derived suppressor cells in cancer and cancer therapy. Nature reviews. Clinical oncology 21 (2) (2024)
Alisa Lepper, Rebekka Bitsch, Feyza Gül Özbay Kurt, Ihor Arkhypov, Samantha Lasser, Jochen Utikal, Viktor Umansky
Melanoma patients with immune-related adverse events after immune checkpoint inhibitors are characterized by a distinct immunological phenotype of circulating T cells and M-MDSCs. Oncoimmunology 12 (1) (2023)
Ihor Arkhypov, Feyza Gül Özbay Kurt, Rebekka Bitsch, Daniel Novak, Vera Petrova, Samantha Lasser, Thomas Hielscher, Christopher Groth, Alisa Lepper, Xiaoying Hu, Wei Li, Jochen Utikal, Peter Altevogt, Viktor Umansky
HSP90α induces immunosuppressive myeloid cells in melanoma via TLR4 signaling. Journal for immunotherapy of cancer 10 (9) (2022)
Rebekka Bitsch, Annina Kurzay, Feyza Özbay Kurt, Carolina De La Torre, Samantha Lasser, Alisa Lepper, Alina Siebenmorgen, Verena Müller, Peter Altevogt, Jochen Utikal, Viktor Umansky
STAT3 inhibitor Napabucasin abrogates MDSC immunosuppressive capacity and prolongs survival of melanoma-bearing mice. Journal for immunotherapy of cancer 10 (3) (2022)
Marlene Vierthaler, Qian Sun, Yiman Wang, Tamara Steinfass, Juliane Poelchen, Thomas Hielscher, Daniel Novak, Viktor Umansky, Jochen Sven Utikal
ADCK2 Knockdown Affects the Migration of Melanoma Cells via MYL6. Cancers 14 (4) (2022)
Ludovica Arpinati, Naomi Kaisar-Iluz, Merav E Shaul, Christopher Groth, Viktor Umansky, Zvi G Fridlender
Tumor-Derived Factors Differentially Affect the Recruitment and Plasticity of Neutrophils. Cancers 13 (20) (2021)
Qian Sun, Daniel Novak, Laura Hüser, Juliane Poelchen, Huizi Wu, Karol Granados, Aniello Federico, Ke Liu, Tamara Steinfass, Marlene Vierthaler, Viktor Umansky, Jochen Sven Utikal
FOXD1 promotes dedifferentiation and targeted therapy resistance in melanoma by regulating the expression of connective tissue growth factor. International journal of cancer 149 (3) (2021)
Rebekka Weber, Zeno Riester, Laura Hüser, Carsten Sticht, Alina Siebenmorgen, Christopher Groth, Xiaoying Hu, Peter Altevogt, Jochen S Utikal, Viktor Umansky
IL-6 regulates CCR5 expression and immunosuppressive capacity of MDSC in murine melanoma. Journal for immunotherapy of cancer 8 (2) (2021)
Fabrice Tolle, Viktor Umansky, Jochen Sven Utikal, Stephanie Kreis, Sabrina Bréchard
Neutrophils in Tumorigenesis: Missing Targets for Successful Next Generation Cancer Therapies? International journal of molecular sciences 22 (13) (2021)
Christopher Groth, Rebekka Weber, Samantha Lasser, Feyza Gül Özbay, Annina Kurzay, Vera Petrova, Peter Altevogt, Jochen Sven Utikal, Viktor Umansky
Tumor promoting capacity of polymorphonuclear myeloid-derived suppressor cells and their neutralization. International journal of cancer 149 (9) (2021)
Christopher Groth, Ludovica Arpinati, Merav E Shaul, Nina Winkler, Klara Diester, Nicolas Gengenbacher, Rebekka Bitsch, Ihor Arkhypov, Samantha Lasser, Vera Petrova, Hellmut G Augustin, Peter Altevogt, Jochen Sven Utikal, Zvi G Fridlender, Viktor Umansky
Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression. Cancers 13 (4) (2021)
Sonja C S Simon, Jochen Utikal, Viktor Umansky
Opposing roles of eosinophils in cancer. Cancer immunology, immunotherapy : CII 68 (5) (2018)
Viktor Umansky, Gosse J Adema, Jaroslaw Baran, Sven Brandau, Jo A Van Ginderachter, Xiaoying Hu, Jadwiga Jablonska, Slavko Mojsilovic, Helen A Papadaki, Yago Pico de Coaña, Kim C M Santegoets, Juan F Santibanez, Karine Serre, Yu Si, Isabela Sieminska, Maria Velegraki, Zvi G Fridlender
Interactions among myeloid regulatory cells in cancer. Cancer immunology, immunotherapy : CII 68 (4) (2018)